leflunomide has been researched along with Bacterial Disease in 1 studies
Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To determine the risk of severe infection requiring or complicating hospitalization associated with leflunomide therapy in patients with rheumatoid arthritis (RA)." | 7.79 | Risk factors of severe infections in patients with rheumatoid arthritis treated with leflunomide. ( Jeon, HS; Jun, JB; Yoo, HG; Yoo, WH; Yu, HM, 2013) |
| "To determine the risk of severe infection requiring or complicating hospitalization associated with leflunomide therapy in patients with rheumatoid arthritis (RA)." | 3.79 | Risk factors of severe infections in patients with rheumatoid arthritis treated with leflunomide. ( Jeon, HS; Jun, JB; Yoo, HG; Yoo, WH; Yu, HM, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yoo, HG | 1 |
| Yu, HM | 1 |
| Jun, JB | 1 |
| Jeon, HS | 1 |
| Yoo, WH | 1 |
1 other study available for leflunomide and Bacterial Disease
| Article | Year |
|---|---|
Risk factors of severe infections in patients with rheumatoid arthritis treated with leflunomide.
Topics: Adrenal Cortex Hormones; Adult; Age Factors; Aged; Aged, 80 and over; Antirheumatic Agents; Arthriti | 2013 |